BEUDAMED
    15 results · 21ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    CAMLOG and CONELOG Abutments for Screw-retained Restorations (ASR)

    FDA 510(k)
    FDA Class 2 ·Dental

    LEONE SPA

    FDA UDI
    LEONE SPA·08033707014270·CALIBRA 1ST MOL BANDS W/G8325-02 n.UR 9

    ARx SAI

    FDA UDI
    Life Spine, Inc.·00190837196196·

    ARx SAI

    FDA UDI
    Life Spine, Inc.·00190837194727·

    Arx

    FDA UDI
    Life Spine, Inc.·00190837175719·

    TRIMED CLAVICLE FIXATION SYSTEM

    FDA 510(k)
    FDA Class 2 ·Orthopedic

    M-BOLUS EMBOLIC MICROSPHERES

    FDA 510(k)
    FDA Class 2 ·Neurology

    HUDSON CONCHA NEPTUNE

    FDA Adverse Event
    Malfunction ·TELEFLEX·Product code BTT·October 6, 2014

    CAPSUREFIX NOVUS

    FDA Adverse Event
    Injury ·MPRI·Product code DTB·June 7, 2013

    HUDSON NEBULIZER, ADAPTORS 033

    FDA Adverse Event
    Malfunction ·TELEFLEX MEDICAL·Product code CAF·June 21, 2011

    SVO2 CCO OPTIQ CATHETER

    FDA Adverse Event
    Malfunction ·ICU MEDICAL, INC.·Product code DQE·May 20, 2013

    VITROS Chemistry Products COCM Reagent

    FDA Enforcement
    Class II ·Terminated·Ortho-Clinical Diagnostics·January 29, 2014

    7245C, 7245C/E, 7245D Computer Digital Video System Product Usage: The 7245C, 7245C/E and 7245D are used to electronically record, display, transfer, and store digital video data of behavior related to swallowing in the pharyngeal area for medical and pedagogical applications.

    FDA Enforcement
    Class II ·Terminated·Pentax of America Inc·July 26, 2017

    ELEKTA LIMITED Elekta Synergy Platform, REF MRT 8501, MRT 8511; Medical Charged-Particle Radiation Therapy System Accelerator, Linear

    FDA Enforcement
    Class II ·Ongoing·Elekta, Inc.·December 13, 2023

    SL & SLi Series (Mod 15/18/20/25) Linear Accelerator Used for radiation therapy treatments of malignant neoplastics diseases.

    FDA Enforcement
    Class II ·Terminated·Elekta, Inc.·March 26, 2014